Aeres, IDRI to Take Preventive and Therapeutic TB Vaccine into Phase I

Nonprofit organizations Aeres and the Infectious Disease Research Institute (IDRI) are teaming up to develop the latter’s tuberculosis vaccine candidate, which is projected to start in clinical trials this year. The vaccine, ID93/GLA-SE, targets both active tuberculosis and latent disease, IDRI claims. The organization anticipates the vaccine could be used both for prophylactic with or [...]